Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre Validation of Hemodynamic Multiparametric Tissue Signature (MTS) Biomarkers From Preoperative and Postradiotherapy MRI in Patients With Glioblastoma: Predictors of Overall Survival

NCT03439332 is registered in ClinicalTrials.gov with Juan M Garcia-Gomez as lead sponsor.

NCT NCT03439332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03439332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre Validation of Hemodynamic Multiparametric Tissue Signature (MTS) Biomarkers From Preoperative and Postradiotherapy MRI in Patients With Glioblastoma: Predictors of Overall Survival
Lead sponsor
Juan M Garcia-Gomez
Phase
Observational
Overall status
Completed
Start date
February 7, 2018
Completion date
March 1, 2019
Enrollment
305 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma